Rep. Gilbert Ray Cisneros, Jr. Acquires Shares of The Cooper Companies, Inc. (NASDAQ:COO)

12 Nov 2026, 23:01 by Jessica Moore · The Cerbat Gem

Representative Gilbert Ray Cisneros, Jr. (Democratic-California) recently bought shares of The Cooper Companies, Inc. (NASDAQ:COO). In a filing disclosed on November 10th, the Representative disclosed that they had bought between $1,001 and $15,000 in Cooper Companies stock on October 14th. The trade occurred in the Representative’s “150 MAIN STREET TRUST > BANK OF AMERICA” account.

Representative Gilbert Ray Cisneros, Jr. also recently made the following trade(s):

Purchased $1,001 – $15,000 in shares of BridgeBio Pharma (NASDAQ:BBIO) on 11/2/2026.
Purchased $1,001 – $15,000 in shares of argenex (NASDAQ:ARGX) on 10/27/2026.
Sold $1,001 – $15,000 in shares of Illumina (NASDAQ:ILMN) on 10/27/2026.
Sold $1,001 – $15,000 in shares of Revvity (NYSE:RVTY) on 10/27/2026.
Sold $15,001 – $50,000 in shares of PTC (NASDAQ:PTC) on 10/27/2026.
Purchased $1,001 – $15,000 in shares of BridgeBio Pharma (NASDAQ:BBIO) on 10/27/2026.
Purchased $1,001 – $15,000 in shares of MACOM Technology Solutions (NASDAQ:MTSI) on 10/27/2026.
Sold $1,001 – $15,000 in shares of Micron Solutions (OTCMKTS:MICR) on 10/21/2026.
Sold $1,001 – $15,000 in shares of Ciena (NYSE:CIEN) on 10/21/2026.
Purchased $1,001 – $15,000 in shares of ServiceNow (NYSE:NOW) on 10/21/2026.

Cooper Companies Price Performance

Shares of NASDAQ COO traded down $0.74 during trading on Thursday, hitting $62.19. 1,949,503 shares of the company were exchanged, compared to its average volume of 2,745,838. The firm’s fifty day moving average price is $58.65 and its 200 day moving average price is $68.24. The company has a debt-to-equity ratio of 0.23, a current ratio of 1.22 and a quick ratio of 0.73. The company has a market cap of $11.83 billion, a price-to-earnings ratio of 21.23, a PEG ratio of 2.47 and a beta of 0.83. The Cooper Companies, Inc. has a 1 year low of $51.01 and a 1 year high of $89.83.

Cooper Companies (NASDAQ:COO – Get Free Report) last released its quarterly earnings data on Wednesday, September 9th. The medical device company reported $1.15 earnings per share for the quarter, beating the consensus estimate of $1.12 by $0.03. Cooper Companies had a return on equity of 10.90% and a net margin of 13.46%. The firm had revenue of $1.07 billion during the quarter, compared to the consensus estimate of $1.10 billion. During the same period last year, the business posted $0.49 EPS. Cooper Companies’s quarterly revenue was up .5% on a year-over-year basis. Cooper Companies has set its Q4 2026 guidance at 1.050-1.090 EPS and its FY 2026 guidance at 4.510-4.550 EPS. On average, sell-side analysts expect that The Cooper Companies, Inc. will post 4.53 earnings per share for the current fiscal year.

Cooper Companies announced that its board has approved a share repurchase plan on Wednesday, September 9th that allows the company to repurchase $3 billion in outstanding shares. This repurchase authorization allows the medical device company to buy up to 22.7% of its shares through open market purchases. Share repurchase plans are generally a sign that the company’s board of directors believes its shares are undervalued.

Insider Activity at Cooper Companies

In related news, Director Lawrence Kurzius bought 10,000 shares of the stock in a transaction dated Wednesday, September 16th. The stock was bought at an average cost of $54.93 per share, with a total value of $549,300.00. Following the completion of the acquisition, the director owned 31,099 shares of the company’s stock, valued at $1,708,268.07. This trade represents a 47.40% increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Walter M. Rosebrough, Jr. bought 3,000 shares of the stock in a transaction dated Monday, September 14th. The shares were bought at an average cost of $54.29 per share, with a total value of $162,870.00. Following the completion of the acquisition, the director directly owned 20,000 shares of the company’s stock, valued at approximately $1,085,800. The trade was a 17.65% increase in their position. The disclosure for this purchase is available in the SEC filing. Insiders acquired a total of 34,701 shares of company stock valued at $1,880,039 in the last quarter. Insiders own 2.08% of the company’s stock.

Analyst Ratings Changes

Several equities analysts have weighed in on the stock. Zacks Research downgraded shares of Cooper Companies from a “hold” rating to a “strong sell” rating in a report on Friday, September 11th. UBS Group reduced their price target on shares of Cooper Companies from $75.00 to $66.00 and set a “neutral” rating on the stock in a report on Thursday, September 10th. Weiss Ratings lowered shares of Cooper Companies from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Wednesday, October 28th. Stifel Nicolaus set a $70.00 target price on shares of Cooper Companies and gave the company a “buy” rating in a research note on Thursday, September 10th. Finally, Barclays raised shares of Cooper Companies to a “hold” rating in a research note on Wednesday, October 7th. Four investment analysts have rated the stock with a Buy rating, twelve have given a Hold rating and three have assigned a Sell rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Hold” and an average target price of $68.60.

Get Our Latest Stock Report on COO

Hedge Funds Weigh In On Cooper Companies

Institutional investors have recently added to or reduced their stakes in the company. BlackRock Inc. acquired a new stake in shares of Cooper Companies in the 2nd quarter valued at about $1,077,762,000. Generation Investment Management LLP acquired a new stake in shares of Cooper Companies during the second quarter worth $356,304,000. Jupiter Topco LLC bought a new position in shares of Cooper Companies in the 2nd quarter worth about $305,074,000. JANA Partners Management LP lifted its position in shares of Cooper Companies by 0.5% in the 2nd quarter. JANA Partners Management LP now owns 3,582,480 shares of the medical device company’s stock worth $256,900,000 after buying an additional 17,322 shares during the last quarter. Finally, Wellington Management Group LLP boosted its holdings in shares of Cooper Companies by 3.1% in the 2nd quarter. Wellington Management Group LLP now owns 3,468,951 shares of the medical device company’s stock valued at $248,758,000 after buying an additional 103,044 shares during the period. Institutional investors and hedge funds own 24.39% of the company’s stock.

About Representative Cisneros

Gil Cisneros (Democratic Party) is a member of the U.S. House, representing California’s 31st Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027.

Cisneros (Democratic Party) is running for re-election to the U.S. House to represent California’s 31st Congressional District. He declared candidacy for the 2026 election.

Gil Cisneros served in the U.S. Navy as a supply officer from 1994 to 2004. Cisneros earned a bachelor’s degree in political science from George Washington University in 1994, a master’s in business administration from Regis University in 2002, and a master’s degree in urban education policy from Brown University in 2015. His career experience includes working as a logistics manager for Frito-Lay. In 2010, Cisneros won the lottery and became involved in activism and philanthropy, founding a scholarship program for local high school students. In 2021, President Joe Biden (D) appointed Cisneros as under secretary of defense for personnel and readiness.

About Cooper Companies

(Get Free Report)

CooperCompanies is a global medical device company focused on vision care and women’s health. It serves customers in markets around the world through two primary businesses: CooperVision and CooperSurgical. CooperVision develops and sells contact lenses, including products for daily wear, astigmatism, presbyopia and myopia management. Its offerings include lenses made from silicone hydrogel and other materials, as well as specialty lens options. CooperSurgical provides products and services for women’s health and fertility care.